Physician profile
Sandy Charles
NPI 1578706685
$7,339.79
in general payments reported to CMS, 2019-2025
19 companies · $3,000 in 2025
The $3,000 reported for 2025 was more than what 88% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $154 · 2020: $64.21 · 2021: $352 · 2022: $429 · 2023: $529 · 2024: $2,812 · 2025: $3,000.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,375 · Food and Beverage: $966.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,375.00 |
| Food and Beverage | $965.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $5,574.17 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $306.67 | 2019-2024 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $250.76 | 2022-2024 | Xarelto |
| Amgen INC. | $221.97 | 2019-2024 | Repatha |
| Esperion Therapeutics, INC. | $149.09 | 2021-2023 | Nexletol |
| Edwards Lifesciences Corporation | $142.84 | 2021 | |
| Pfizer INC. | $113.96 | 2022-2024 | |
| Alnylam Pharmaceuticals INC. | $108.74 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $101.54 | 2022-2024 | Jardiance |
| Heartflow, INC. | $76.94 | 2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $66.76 | 2019-2021 | |
| Scpharmaceuticals INC. | $43.04 | 2023-2024 | |
| Cvrx, INC. | $37.79 | 2024 | Barostim Neo System |
| Lexicon Pharmaceuticals, INC. | $37.58 | 2023-2024 | Inpefa |
| Genzyme Corporation | $28.31 | 2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals International, Plc | $25.88 | 2024 | Arcalyst |
| Tactile Systems Technology INC | $24.88 | 2024 | Entre Plus, Flexitouch Plus |
| Lantheus Medical Imaging, INC. | $15.11 | 2019 | |
| Medicure Pharma INC. | $13.76 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandy Charles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.